审校:Tony
治疗过程中,我们追踪其常规实验室指标,发现一组“不对劲”的信号:血小板与血红蛋白同步下降;D-二聚体升高,PT、APTT轻度延长;同时LDH由133 U/L升至864 U/L;总胆红素由16.0μmol/L升至59.8μmol/L,具体趋势图如下:
随后检验科TTP筛查系统通过患者血常规、生化常规结果识别出了患者存在血小板显著减低+血管内溶血可能,发出了警报:
评估筛查结果后,我们检测ADAMTS13活性及其IgG抗体并同步了解患者外周血涂片情况:可见裂红细胞明显增多,比例达5.4%。
随后的ADAMTS13检测结果证实了我们的判断:ADAMTS13活性<3.0%(参考范围50-150%),显著缺乏。ADAMTS13抗体达104 U/mL(参考范围<5 U/mL),将患者前几天的样本找出来检测ADAMTS13抗体,可见一周前还在阴性水平,3天前已经变阳性了(11.4U/mL,当天血小板计数还在正常水平),进展迅速:
综合诊断:食管支气管瘘、肺部感染合并自身免疫性血栓性血小板减少性紫(iTTP)。
参考文献
[1]Scully M,Rayment R,Clark A,et al.A British Society for Haematology Guideline:Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.Br J Haematol,2023,203(4):546-563.
[2]中华医学会血液学分会血栓与止血学组.血栓性血小板减少性紫癜诊断与治疗中国指南(2022年版).中华血液学杂志,2022,43(1):7-12.
[3]Laghmouchi A,Graça NAG,Voorberg J.Emerging concepts in immune thrombotic thrombocytopenic purpura.Front Immunol,2021,12:757192.
[4]Trisolini SM,LaganàA,Capria S.Immune thrombotic thrombocytopenic purpura:pathophysiology,diagnosis,therapy and open issues.Mediterr J Hematol Infect Dis,2024,16(1):e2024060.
[5]Kosugi N,Tsurutani Y,Isonishi A,et al.Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor.Intern Med,2010,49(8):689-693.
[6]Bitzan M,Zieg J.Influenza-associated thrombotic microangiopathies.Pediatr Nephrol,2018,33(11):2009-2025.
转载至血栓与止血检查by Tony